Literature DB >> 15757582

[Enzymatic resistance to beta lactam antibiotics within the genus Proteus and evaluation of Proteus mirabilis phenotypes and genotypes for resistance to third- and fourth-generation cephalosporins].

Cynthia Rodríguez1, Marcela Radice, Beatriz Perazzi, Silvia Castro, Josefina Juárez, Pilar Santini, Carlos Vay, Angela Famiglietti, Gabriel Gutkind.   

Abstract

INTRODUCTION: The aim of this study was to evaluate betalactam resistance within the genus Proteus and characterize the betalactamases responsible for this resistance.
METHODS: We analyzed 99 strains (87, P. mirabilis; 10 P. vulgaris, and 2, P. penneri) isolated from patients at one University Hospital. Antibiotic susceptibility tests were performed according to NCCLS recommendations. Presence of extended spectrum betalactamases (ESBL) was inferred by both double disk diffusion tests and minimum inhibitory concentration (MIC) of third and fourth generation cephalosporins alone and in the presence of clavulanic acid. Isoelectric points (pI) of the enzymes were estimated by isoelectrofocusing and the presence of the encoding genes was confirmed by polymerase chain reaction (PCR).
RESULTS: A broad spectrum betalactamase could be detected in those isolates (28%) resistant to penicillin and first generation cephalosporins while CTX-M-2 enzyme could be detected in P. mirabilis isolates resistant to third and fourth generation cephalosporins (18%). One of the P. vulgaris displayed reduced susceptibility to cefotaxime due to an enzyme of pI 7.4, while resistance to cefotaxime in one P. penneri was related to an enzyme of pI 6.8. Both enzymes were active on cefotaxime (1,000 mg/l) in the iodometric assay.
CONCLUSION: The broad extended spectrum betalactamase within genus Proteus was TEM-1, while CTX-M-2 was the ESBL responsible for the third and fourth generation cephalosporins in P. mirabilis. In P. vulgaris and P. penneri this resistance was associated with the hyperproduction of the chromosomal encoded betalactamase.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15757582     DOI: 10.1157/13072160

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  3 in total

1.  CMY-16, a novel acquired AmpC-type beta-lactamase of the CMY/LAT lineage in multifocal monophyletic isolates of Proteus mirabilis from northern Italy.

Authors:  Marco M D'Andrea; Elisabetta Nucleo; Francesco Luzzaro; Tommaso Giani; Roberta Migliavacca; Francesca Vailati; Vesselina Kroumova; Laura Pagani; Gian Maria Rossolini
Journal:  Antimicrob Agents Chemother       Date:  2006-02       Impact factor: 5.191

2.  OXA-258 from Achromobacter ruhlandii: a species-specific marker.

Authors:  Mariana Papalia; Marisa Almuzara; Daniela Cejas; German Traglia; Maria Soledad Ramírez; Laura Galanternik; Carlos Vay; Gabriel Gutkind; Marcela Radice
Journal:  J Clin Microbiol       Date:  2013-03-06       Impact factor: 5.948

3.  Isolation, identification & characterization of Proteus penneri--a missed rare pathogen.

Authors:  Janak Kishore
Journal:  Indian J Med Res       Date:  2012-03       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.